Bell Investment Advisors’s Globus Medical GMED Stock Holding History

Bell Investment Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$870	Sell	11 -6	-35%	-$510	﹤0.01%	1566
2026 Q1	$1.47K	Sell	17 -59	-78%	-$5.3K	﹤0.01%	1439
2025 Q4	$6.64K	Buy	76 +34	+81%	+$2.58K	﹤0.01%	866
2025 Q3	$2.41K	Sell	42 -15	-26%	-$864	﹤0.01%	1268
2025 Q2	$3.37K	Hold	57	–	–	﹤0.01%	1153
2025 Q1	$4.17K	Hold	57	–	–	﹤0.01%	1000
2024 Q4	$4.71K	Buy	57 +6	+12%	+$473	﹤0.01%	950
2024 Q3	$3.65K	Sell	51 -10	-16%	-$706	﹤0.01%	1091
2024 Q2	$4.18K	Buy	61 +10	+20%	+$597	﹤0.01%	1010
2024 Q1	$2.74K	Hold	51	–	–	﹤0.01%	1214
2023 Q4	$2.72K	Sell	51 -52	-50%	-$2.53K	﹤0.01%	1198
2023 Q3	$5.11K	Buy	103 +31	+43%	+$1.73K	﹤0.01%	795
2023 Q2	$4.29K	Sell	72 -9	-11%	-$513	﹤0.01%	903
2023 Q1	$4.59K	Buy	81 +10	+14%	+$641	﹤0.01%	832
2022 Q4	$5.27K	Buy	71 +28	+65%	+$1.91K	﹤0.01%	779
2022 Q3	$3K	Hold	43	–	–	﹤0.01%	912
2022 Q2	$2K	Buy	+43	New	+$2.83K	﹤0.01%	1147
2021 Q4	$2K	Hold	34	–	–	﹤0.01%	1144
2021 Q3	$3K	Buy	+34	New	+$2.73K	﹤0.01%	917

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bell Investment Advisors's GMED Position: Q2 2026 in Review

Bell Investment Advisors reduced its Globus Medical (GMED) stake by 35% in Q2 2026, selling an estimated $510 and leaving 11 shares worth $870. The position accounts for ﹤0.01% of the portfolio, ranked #1566.

Bell Investment Advisors first reported a position in GMED in Q3 2021 and has held it in 19 quarters since. The position peaked at $6.64K in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Bell Investment Advisors held 11 shares of Globus Medical worth $870 as of Q2 2026.
Bell Investment Advisors sold 6 Globus Medical shares in Q2 2026, an estimated $510.
Globus Medical made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1566 holding.
Bell Investment Advisors first reported a position in Globus Medical in Q3 2021 and has held it in 19 quarters since.
Bell Investment Advisors's Globus Medical position peaked at $6.64K in Q4 2025.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.